1Kota BP,Huang TH,Roufogalis BD.An overview on biological mechanisms of PPARs[J].Pharmacol Res,2005,51 (2):85-94.
2Israelian KZ,Reaven PD.Peroxisome proliferator-activated receptor-alpha and atherosclerosis; from basic mechanisms to clinical implications[J].Cardiology,2005,103 (1):1-9.
3Blaschke F,Bruemmer D,Law RE.Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting[J].Clin Cardiol,2004,27 (Suppl 4):Ⅳ3-Ⅳ10.
6Ricote M,Huang J,Fajas L,et al.Expression of the peroxisome proliferator-activated receptor-γ (PPAR-γ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein[J].Proc Natl Acad Sci USA,1998,95 (13):7614-7619.
7Koshiyama H,Shimono D,Kuwamura N,et al.Rapid communication:Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes[J].J Clin Endocrinol Metab,2001,86 (7):3452-3456.
8Malerod L,Sporstol M,Juvet LK,et al.Hepatic scavenger receptor class B,type Ⅰ is stimulated by peroxisome proliferatoractivated receptor gamma and hepatocyte nuclear factor 4 alpha[J].Biochem Biophys Res Commun,2003,305 (3):557-565.
